Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Freenome Nabs $290M Investment From Roche

2022-01-11
SOUTH SAN FRANCISCO, CA, Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 million.
Freenome announced today that Roche has made an investment of $290 million, bringing Freenome's total funding to more than $1.1 billion since the company was founded in 2014. This announcement follows Freenome's recent Series D financing of $300 million in December.

Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors